Antibody-drug conjugates in metastatic triple negative breast cancer: a spotlight on sacituzumab govitecan, ladiratuzumab vedotin, and trastuzumab deruxtecan-Reference-Cited by-同舟云学术

Antibody-drug conjugates in metastatic triple negative breast cancer: a spotlight on sacituzumab govitecan, ladiratuzumab vedotin, and trastuzumab deruxtecan

Published:2020-12-27 Issue:7 Volume:21 Page:903-913
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

McGuinness Julia E.¹^ORCID,Kalinsky Kevin²

Affiliation:

1. Department of Medicine, Division of Hematology and Oncology, Columbia University Irving Medical Center, New York, NY, USA

2. Department of Medicine, Division of Hematology and Oncology, Emory University School of Medicine, Atlanta, GA, USA

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2021.1840547

Reference73 articles.

1. Update on triple‐negative breast cancer disparities for the United States: A population‐based study from the United States Cancer Statistics database, 2010 through 2014

2. Breast cancer statistics, 2019

3. The epidemiology of triple-negative breast cancer, including race

4. Features of triple-negative breast cancer

5. Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors;Cancer Cell International;2024-04-10

2. Research Progress of Treatment Modalities and Related Drugs for Triple Negative Breast Cancer;Advances in Clinical Medicine;2024

3. Importance of Physical Medicine and Rehabilitation in a Patient With Bilateral Lumbosacral Plexopathy Following the Course of Ladiratuzumab Vedotin for Breast Cancer: A Case Report;Cureus;2023-12-01

4. Emerging treatment approaches for triple-negative breast cancer;Medical Oncology;2023-12-01

5. Antibody–Drug Conjugates in Breast Cancer: Current Status and Future Directions;International Journal of Molecular Sciences;2023-09-06